Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopy
While nanocarrier-based drug delivery is a promising therapeutic approach, in situ characterization of drug nanocarriers in blood remains difficult. Here, the authors demonstrate how the fluorescence correlation spectroscopy can be used to directly characterize drug nanocarriers in flowing blood.
Main Authors: | Inka Negwer, Andreas Best, Meike Schinnerer, Olga Schäfer, Leon Capeloa, Manfred Wagner, Manfred Schmidt, Volker Mailänder, Mark Helm, Matthias Barz, Hans-Jürgen Butt, Kaloian Koynov |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-07755-0 |
Similar Items
-
Site-Specific DBCO Modification of DEC205 Antibody for Polymer Conjugation
by: Simone Beck, et al.
Published: (2018-02-01) -
The challenges of oral drug delivery via nanocarriers
by: Jonas Reinholz, et al.
Published: (2018-01-01) -
Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions
by: Raweewan Thiramanas, et al.
Published: (2020-09-01) -
Multivalency Beats Complexity: A Study on the Cell Uptake of Carbohydrate Functionalized Nanocarriers to Dendritic Cells
by: Matthias Krumb, et al.
Published: (2020-09-01) -
Prevention of Dominant IgG Adsorption on Nanocarriers in IgG‐Enriched Blood Plasma by Clusterin Precoating
by: Domenik Prozeller, et al.
Published: (2019-05-01)